Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs

Journal of Hepatology

Volumn 44, Issue 2, 2006, Pages 317-324

  Li, Lan Juan ^a   Du, Wei Bo ^a   Zhang, Yi Min ^a   Li, Jun ^a   Pan, Xiao Ping ^a   Chen, Jia Jia ^a   Cao, Hong Cui ^a   Chen, Yu ^a   Chen, Yue Mei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bioartificial liver; Bioreactor; D galactosamine; Hepatic failure; Hepatocyte; Nonwoven fabric; Pig

Indexed keywords

AMMONIA; GALACTOSAMINE; GLUCOSE; LACTIC ACID;

AMMONIA BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOARTIFICIAL LIVER; BIOREACTOR; COMPARATIVE STUDY; CONTROLLED STUDY; FULMINANT LIVER FAILURE; GLUCOSE BLOOD LEVEL; INTENSIVE CARE; LACTATE BLOOD LEVEL; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; SWINE; TREATMENT OUTCOME;

ANIMALS; BIOREACTORS; DISEASE MODELS, ANIMAL; EQUIPMENT DESIGN; GALACTOSAMINE; HEMOPERFUSION; HEPATOCYTES; LIVER FAILURE, ACUTE; LIVER, ARTIFICIAL; MALE; SWINE; SWINE, MINIATURE; TEXTILES; TREATMENT OUTCOME;

EID: 30344483194     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.08.006     Document Type: Article

References (56)

1. A.O. Shakil, D. Kramer, G.V. Mazariegos, J.J. Fung, and J. Rakela Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria Liver Transpl 6 2000 163 169
2. A. Mas, and J. Rodes Fulminant hepatic failure Lancet 349 1997 1081 1085
3. R.W. Chapman, D. Forman, R. Peto, and R. Smallwood Liver transplantation for acute hepatic failure? Lancet 335 1990 32 35
4. G. Ostapowicz, and W.M. Lee Acute hepatic failure: a Western perspective J Gastroenterol Hepatol 15 2000 480 488
5. B. van Hoek, J. de Boer, K. Boudjema, R. Williams, O. Corsmit, and O.T. Terpstra Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry J Hepatol 30 1999 699 705
6. S. Miwa, Y. Hashikura, A. Mita, T. Kubota, H. Chisuwa, and Y. Nakazawa Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure Hepatology 30 1999 1521 1526
7. J.A. Goss, C.R. Shackleton, M. Maggard, K. Swenson, P. Seu, and S.V. McDiarmid Liver transplantation for fulminant hepatic failure in the pediatric patient Arch Surg 133 1998 839 846
8. C.O. Esquivel, E.B. Keeffe, G. Garcia, J.C. Imperial, M.T. Millan, and H. Monge Resection versus transplantation for hepatocellular carcinoma J Gastroenterol Hepatol 14 1999 S37 S41
9. A.L. Friedman Why bioartificial liver support remains the Holy Grail ASAIO J 44 1998 241 243
10. P. Caraceni, and D.H. Van Thiel Acute liver failure Lancet 345 1995 163 169
11. S.D. Lidofsky Liver transplantation for fulminant hepatic failure Gastroenterol Clin North Am 22 1993 257 269
12. R.D. Hughes, and R. Williams Use of bioartificial and artificial liver support devices Semin Liver Dis 16 1996 435 444
13. V. Dixit, and G. Gitnick The bioartificial liver: state-of-the-art Eur J Surg Suppl 1998 71 76
14. S. Nagamori, S. Hasumura, T. Matsuura, H. Aizaki, and M. Kawada Developments in bioartificial liver research: concepts, performance, and applications J Gastroenterol 35 2000 493 503
15. B. Busse, and J.C. Gerlach Bioreactors for hybrid liver support: historical aspects and novel designs Ann N Y Acad Sci 875 1999 326 339
16. J.W. Allen, T. Hassanein, and S.N. Bhatia Advances in bioartificial liver devices Hepatology 34 2001 447 455
17. A.J. Strain, and J.M. Neuberger A bioartificial liver - state of the art Science 295 2002 1005 1009
18. N.L. Sussman, G.T. Gislason, C.A. Conlin, and J.H. Kelly The Hepatix extracorporeal liver assist device: initial clinical experience Artif Organs 18 1994 390 396
19. A.A. Demetriou, R.S. Brown Jr., R.W. Busuttil, J. Fair, B.M. McGuire, and P. Rosenthal Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure Ann Surg 239 2004 660 667 [discussion 667-670]
20. A.J. Ellis, R.D. Hughes, J.A. Wendon, J. Dunne, P.G. Langley, and J.H. Kelly Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure Hepatology 24 1996 1446 1451
21. F.D. Watanabe, C.J. Mullon, W.R. Hewitt, N. Arkadopoulos, E. Kahaku, and S. Eguchi Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial Ann Surg 225 1997 484 491 discussion 491-484
22. G.V. Mazariegos, D.J. Kramer, R.C. Lopez, A.O. Shakil, A.J. Rosenbloom, and M. DeVera Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients Asaio J 47 2001 471 475
23. E. Morsiani, P. Pazzi, A.C. Puviani, M. Brogli, L. Valieri, and P. Gorini Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients Int J Artif Organs 25 2002 192 202
24. A. Mundt, G. Puhl, A. Muller, I. Sauer, C. Muller, and R. Richard A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support Int J Artif Organs 25 2002 542 548
25. A. Donini, U. Baccarani, A. Risaliti, A. Degrassi, and F. Bresadola Temporary neurological improvement in a patient with acute or chronic liver failure treated with a bioartificial liver device Am J Gastroenterol 95 2000 1102 1104
26. M.P. van de Kerkhove, E. Di Florio, V. Scuderi, A. Mancini, A. Belli, and A. Bracco Phase I clinical trial with the AMC-bioartificial liver Int J Artif Organs 25 2002 950 959
27. P.D. Hay, A.R. Veitch, M.D. Smith, R.B. Cousins, and J.D. Gaylor Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver Artif Organs 24 2000 278 288
28. P.D. Hay, A.R. Veitch, and J.D. Gaylor Oxygen transfer in a convection-enhanced hollow fiber bioartificial liver Artif Organs 25 2001 119 130
29. J.F. Patzer II Oxygen consumption in a hollow fiber bioartificial liver - revisited Artif Organs 28 2004 83 98
30. M. Shito, A.W. Tilles, R.G. Tompkins, M.L. Yarmush, and M. Toner Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure J Surg Res 111 2003 53 62
31. M. Maruyama, T. Totsugawa, T. Kunieda, T. Okitsu, N. Shibata, and M. Takesue Hepatocyte isolation and transplantation in the pig Cell Transplant 12 2003 593 598
32. K. Kalpana, H.S. Ong, K.C. Soo, S.Y. Tan, and J. Prema Raj An improved model of galactosamine-induced fulminant hepatic failure in the pig J Surg Res 82 1999 121 130
33. J.C. Gerlach Long-term liver cell cultures in bioreactors and possible application for liver support Cell Biol Toxicol 13 1997 349 355
34. L.M. Flendrig, J.W. la Soe, G.G. Jorning, A. Steenbeek, O.T. Karlsen, and W.M. Bovee In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates J Hepatol 26 1997 1379 1392
35. M.P. van de Kerkhove, R. Hoekstra, T.M. van Gulik, and R.A. Chamuleau Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research Biomaterials 25 2004 1613 1625
36. J. Terblanche, and R. Hickman Animal models of fulminant hepatic failure Dig Dis Sci 36 1991 770 774
37. D. Keppler, R. Lesch, W. Reutter, and K. Decker Experimental hepatitis induced by D-galactosamine Exp Mol Pathol 9 1968 279 290
38. A. Medline, F. Schaffner, and H. Popper Ultrastructural features in galactosamine-induced hepatitis Exp Mol Pathol 12 1970 201 211
39. A.M. Jonker, F.W. Dijkhuis, F.G. Kroese, M.J. Hardonk, and J. Grond Immunopathology of acute galactosamine hepatitis in rats Hepatology 11 1990 622 627
40. R. Williams, and A.E. Gimson Intensive liver care and management of acute hepatic failure Dig Dis Sci 36 1991 820 826
41. W.R. Ellis, P.K. Chu, and I.M. Murray-Lyon The influence of ammonia and octanoic acid on liver regeneration in the rat Clin Sci (London) 56 1979 95 97
42. L. Zieve, M. Shekleton, C. Lyftogt, and K. Draves Ammonia, octanoate and a mercaptan depress regeneration of normal rat liver after partial hepatectomy Hepatology 5 1985 28 31
43. J.F. Patzer II, G.V. Mazariegos, and R. Lopez Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System J Am Coll Surg 195 2002 299 310
44. L.M. Flendrig, R.A. Chamuleau, M.A. Maas, J. Daalhuisen, B. Hasset, and C.G. Kilty Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability J Hepatol 30 1999 311 320
45. T.D. Sielaff, M.Y. Hu, B. Amiot, M.D. Rollins, S. Rao, and B. McGuire Gel-entrapment bioartificial liver therapy in galactosamine hepatitis J Surg Res 59 1995 179 184
46. V. Cuervas-Mons, A. Colas, J.A. Rivera, and E. Prados In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs Transplantation 69 2000 337 344
47. J. Uchino, T. Tsuburaya, F. Kumagai, T. Hase, T. Hamada, and T. Komai A hybrid bioartificial liver composed of multiplated hepatocyte monolayers ASAIO Trans 34 1988 972 977
48. J. Rozga, F. Williams, M.S. Ro, D.F. Neuzil, T.D. Giorgio, and G. Backfisch Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells Hepatology 17 1993 258 265
49. J. Rozga, M.D. Holzman, M.S. Ro, D.W. Griffin, D.F. Neuzil, and T. Giorgio Development of a hybrid bioartificial liver Ann Surg 217 1993 502 509 discussion 509-511
50. L.M. Flendrig, F. Calise, E. Di Florio, A. Mancini, A. Ceriello, and W. Santaniello Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver Int J Artif Organs 22 1999 701 709
51. J. Tsiaoussis, P.N. Newsome, L.J. Nelson, P.C. Hayes, and J.N. Plevris Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl 7 2001 2 10
52. D.C. Mears, G. Stewart, J. Sun, K. Woodman, R. Bourne, and L. Wang Experience with a porcine hepatocyte-based bioartificial liver support system Transplant Proc 35 2003 441 442
53. U. Martin, M.E. Winkler, M. Id, H. Radeke, L. Arseniev, and Y. Takeuchi Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV) Xenotransplantation 7 2000 138 142
54. C. Patience, Y. Takeuchi, and R.A. Weiss Infection of human cells by an endogenous retrovirus of pigs Nat Med 3 1997 282 286
55. R. Kuddus, J.F. Patzer, R. Lopez, G.V. Mazariegos, B. Meighen, and D.J. Kramer Valuation of transmission of porcine endogenous retrovirus into patients subjected to hemoperfusion using an extracorporeal bioartificial liver support system Transplant Proc 33 2001 1976
56. E. Falasca, V. Adami, G. Astori, A. Donini, F. Biffoni, and A. Degrassi Porcine endogenous retrovirus does not infect human cells using a bioartificial liver model system Transplant Proc 33 2001 1780 1781